Vibrio Diagnostics Market Size, Share & Trends Report

Vibrio Diagnostics Market Size, Share & Trends Analysis Report By Technology, By End Use, By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

  • Published Date: ---
  • Base Year for Estimate: ---
  • Report ID: GVR1013
  • Format: Electronic (PDF)
  • Historical Data: ---
  • Number of Pages: 0

The global vibrio diagnostics market has increased healthcare expenditure, rising awareness, advancement in the diagnostics techniques such as enzyme immunoassays (EIA) and polymerase chain reaction (PCR), along with affordability of diagnostics devices and kits and rapid diagnostics tests as its major drivers in the coming years. Growing peri-urban slums, uncooked and raw seafood intake, inadequacy of clean water and improper sanitation, unhygienic living conditions are the important factors for the growth of cholera and other diseases during the forecast period. Favorable living environment for the bacteria due to the global warming is considered to be the other important factor leading to the growth of diseases thereby leading to the growth of market. Vibrio bacteria are mostly found in estuarine and marine environment. To some extent they are also available in the freshwater environment and are usually found in subtropic and temperate waters. Various species of vibrio causes seafood borne illness such as wound infections and septicaemia. There are almost dozen of species that can cause diseases in humans and accounted for 100 deaths, 500 hospitalizations and 80,000 illnesses in the U.S every year. 

Vibrio diagnostics market is segmented into technology and end users. Technology has been further classified into PCR, monoclonal antibodies, flow cytometry, enzyme immunoassays (EIA), diagnostic imaging, immunoprecipitation, Fluorescent immunoassays and immune-PCR. End-users of vibrio diagnostics market includes hospitals, Public Health Laboratories, Private diagnostic labs and commercial diagnostic labs 

Geographically, Vibrio diagnostics market is studied with respect to four regions as North America, Europe, RoW and Asia Pacific. Recently, new variant strains have been identified in some parts of Africa and Asia and according to the observations they are expected to cause severe cholera with increasing cases of fatality rates. Inadequate environmental management in the growing economies of Asia Pacific such as India and China owing to the rising population and pollution is expected to drive the market during the forecast period. According to CDC, there is an average of 16 deaths, 45 hospitalizations and 50 confirmed cases along the Gulf Coast each year. 

Some of the key players in this market are Dickinson and Company, Lonza Group, Abbott Laboratories, DiamedixImpex S.A., Novartis Diagnostics, Kreatech Holding BV, F. Hoffmann-La Roche Ltd, Fujirebio Diagnostics Inc., Becton and Eiken Chemical Co. Ltd.

Key questions answered by the report
Request for Customization

Pricing & Purchase Options

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified